The mode of action and complications of Infant Gaviscon.
D000328:Adult; D000464:Alginates / Q000009:adverse effects*; D000536:Aluminum Hydroxide / Q000009:adverse effects*; D000863:Antacids / Q000009:adverse effects*; D001639:Bicarbonates / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D005503:Food Additives / Q000009:adverse effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007223:Infant; D007225:Infant Food / Q000009:adverse effects*; D007231:Infant, Newborn; D007234:Infant, Premature; D012824:Silicic Acid / Q000009:adverse effects*; D012822:Silicon Dioxide / Q000009:adverse effects*; D017693:Sodium Bicarbonate; D013272:Stomach Diseases / Q000209:etiology
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D004338:Drug Combinations; D005503:Food Additives; D012824:Silicic Acid; D000536:Aluminum Hydroxide; C007829:alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination; D012822:Silicon Dioxide; D017693:Sodium Bicarbonate